LEPTIN RECEPTORS EXPRESSION IN MAMMARY TUMORS AND MAMMARY FAT PAD OF TRANSGENIC MAMMARY CANCER MOUSE MODEL
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.18941Keywords:
leptin, leptin receptor, mammary fat pad, mammary tumor, MMTV-TGF-α miceAbstract
Background: Leptin is an adipokine encoded by the Ob (obese) gene and predominantly produced by adipocytes. The roles of both leptin and leptin receptor (ObR) in numerous pathophysiological conditions including mammary tumor (MT) development have been reported. Aim: To examine protein expression levels of leptin and its receptors (ObR) including the long form, ObRb, in MT tissue and mammary fat pad of a transgenic mammary cancer mouse model. Further, we investigated whether the effects of leptin on MT development are systemic or local. Materials and Methods: MMTV-TGF-α transgenic female mice were fed ad libitum from week 10 up to week 74. Protein expression levels of leptin, ObR, and ObRb were measured in the mammary tissue samples of 74-week old MMTV-TGF-α mice with and without MT (MT-positive/MT-negative) by Western blot analysis. Serum leptin levels were measured by using the mouse adipokine LINCOplex kit 96-well plate assay. Results: Protein expression levels of ObRb were significantly lower in MT as compared to control tissue of mammary gland. In addition, protein expression levels of leptin were significantly higher in the MT tissue of MT-positive mice compared to control tissue of MT-negative mice. However, ObR protein expression levels in tissues of mice with and without MT were similar. Serum leptin levels at different ages were not significantly different between the two groups. Conclusion: Leptin and ObRb in the mammary tissue may play a critical role in the mammary cancer development, while contribution of short ObR isoform may be less important.
References
Izquierdo AG, Crujeiras AB, Casanueva FF, et al. Leptin, obesity, and leptin resistance: where are we 25 years later? Nutrients 2019; 11: 2704. doi:10.3390/nu11112704
Juárez-Cruz JC, Zuñiga-Eulogio MD, Olea-Flores M, et al. Leptin induces cell migration and invasion in a FAK-Src-dependent manner in breast cancer cells. Endocr Connect 2019; 8: 1539–52. doi:10.1530/EC-19-0442
Münzberg H, Morrison CD. Structure, production and signaling of leptin. Metabolism 2015; 64: 13–23. doi:10.1016/j.metabol.2014.09.010
Everitt AV, Porter BD, Wyndham JR. Effects of caloric intake and dietary composition on the development of proteinuria, age-associated renal disease and longevity in the male rat. Gerontology 1982; 28: 168–75. doi:10.1159/000212530
Dogan S, Cicekdal MB, Ozorhan U, et al. Roles of adiponectin and leptin signaling-related micrornas in the preventive effects of calorie restriction in mammary tumor development. Appl Physiol Nutr Metab 2021; 46: 866–76. doi:10.1139/APNM-2020-1000/ SUPPL_FILE/APNM-2020-1000SUPPLA.DOCX
Dogan S, Rogozina OP, Lokshin AE, et al. Effects of chronic vs. intermittent calorie restriction on mammary tumor incidence and serum adiponectin and leptin levels in MMTV-TGF-α mice at different ages. Oncol Lett 2010; 1: 167–76. doi:10.3892/OL_00000031/HTML
Dogan S, Hu X, Zhang Y, et al. Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-α mice. Breast Cancer Res 2007; 9: 1–15. doi:10.1186/bcr1840
Malik KF, Young WS. Localization of binding sites in the central nervous system for leptin (OB protein) in normal, obese (ob/ob), and diabetic (db/db) C57BL/6J mice. Endocrinology 1996; 137: 1497–500. doi:10.1210/endo.137.4.8625929
Briscoe CP, Hanif S, Arch JRS, et al. Leptin receptor long-form signalling in a human liver cell line. Cytokine 2001; 14: 225–9. doi:10.1006/cyto.2001.0871
Tsuchiya T, Shimizu H, Horie T, et al. Expression of leptin receptor in lung: Leptin as a growth factor. Eur J Pharmacol 1999; 365: 273–9. doi:10.1016/S0014-2999(98)00884-X
Choi JH, Park SH, Leung PCK, et al. Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J Clin Endocrinol Metab 2005; 90: 207–10. doi:10.1210/jc.2004-0297
Somasundar P, Frankenberry KA, Skinner H, et al. Prostate cancer cell proliferation is influenced by leptin. J Surg Res 2004; 118: 71–82. doi:10.1016/j.jss.2004.01.017
Linares RL, Benítez JGS, Reynoso MO, et al. Modulation of the leptin receptors expression in breast cancer cell lines exposed to leptin and tamoxifen. Sci Rep 2019; 9: 19189. doi:10.1038/s41598-019-55674-x
Haque I, Ghosh A, Acup S, et al. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway. BMC Cancer 2018; 18: 99. doi:10.1186/s12885-018-3993-6
Kumar J, Fang H, McCulloch DR, et al. Leptin receptor signaling via Janus kinase 2/Signal transducer and activator of transcription 3 impacts on ovarian cancer cell phenotypes. Oncotarget 2017; 8: 93530–40. doi:10.18632/oncotarget.19873
Zahid H, Subbaramaiah K, Iyengar NM, et al. Leptin regulation of the p53-HIF1α/PKM2-Aromatase axis in breast adipose stromal cells: A novel mechanism for the obesity-breast cancer link. Int J Obes 2018; 42: 711–20. doi:10.1038/ijo.2017.273
Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004; 10: 4325–31. doi:10.1158/1078-0432.CCR-03-0749
Sánchez-Jiménez F, Pérez-Pérez A, de la Cruz-Merino L, et al. Obesity and breast cancer: role of leptin. Front Oncol 2019; 9: 596. doi:10.3389/fonc.2019.00596
Garofalo C, Koda M, Cascio S, et al. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: Possible role of obesity-related stimuli. Clin Cancer Res 2006; 12: 1447–53. doi:10.1158/1078-0432.CCR-05-1913
Liu CR, Li Q, Hou C, et al. Changes in body mass index, leptin, and leptin receptor polymorphisms and breast cancer risk. DNA Cell Biol 2018; 37: 182–8. doi:10.1089/dna.2017.4047
Barone I, Giordano C, Bonofiglio D, et al. Leptin, obesity and breast cancer: progress to understanding the molecular connections. Curr Opin Pharmacol 2016; 31: 83–9. doi:10.1016/j.coph.2016.10.003
Ghasemi A, Saeidi J, Azimi-Nejad M, et al. Leptin-induced signaling pathways in cancer cell migration and invasion. Cell Oncol 2019; 42: 243–60. doi:10.1007/s13402-019-00428-0
Zhang Y, Liu L, Li C, et al. Correlation analysis between the expressions of leptin and its receptor (ObR) and clinicopathology in endometrial cancer. Cancer Biomarkers 2014; 14: 353–9. doi:10.3233/CBM-140415
Uddin S, Bu R, Ahmed M, et al. Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer. Mol Cancer 2009; 8: 74. doi:10.1186/1476-4598-8-74
Kato S, Abarzua-Catalan L, Trigo C, et al. Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: An explanation for poor outcomes in obese women. Oncotarget 2015; 6: 21100–19. doi:10.18632/oncotarget.4228
Pan H, Deng LL, Cui JQ, et al. Association between serum leptin levels and breast cancer risk. Medicine 2018; 97: e11345. doi:10.1097/MD.0000000000011345
Strong AL, Ohlstein JF, Biagas BA, et al. Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Res 2015; 17: 112. doi:10.1186/s13058-015-0622-z
Cleary MP, Phillips FC, Getzin SC, et al. Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors. Breast Cancer Res Treat 2003; 77: 205–15. doi:10.1023/A:1021891825399
Cleary MP, Juneja SC, Phillips FC, et al. Leptin receptor-deficient MMTV-TGF-α/LeprdbLepr db female mice do not develop oncogene-induced mammary tumors. Exp Biol Med 2004; 229: 182–93. doi:10.1177/153537020422900207
Chen DC, Chung YF, Yeh YT, et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 2006; 237: 109–14. doi:10.1016/j.canlet.2005.05.047
Miyoshi Y, Funahashi T, Tanaka S, et al. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 2006; 118: 1414–9. doi:10.1002/ijc.21543
Stattin P, Söderberg S, Biessy C, et al. Plasma leptin and breast cancer risk: A prospective study in northern Sweden. Breast Cancer Res Treat 2004; 86: 191–6. doi:10.1023/B:BREA.0000036782.11945.d7
Panico L, D’Antonio A, Salvatore G, et al. Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int J Cancer 1996; 65: 51–6. doi:10.1002/ (SICI)1097-0215(19960103)65:1<51::AID-IJC9>3.0.CO;2-0
Matsui Y, Halter SA, Holt JT, et al. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell 1990; 61: 1147–55. doi:10.1016/ 0092-8674(90)90077-R
Cleary MP. Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus- transforming growth factor-α female mice. CEBP 2002; 11: 836–43.
Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993; 123: 1939–51. doi:10.1093/jn/123.11.1939
Demirel PB, Dogan S, Ozorhan U, et al. Effects of leptin on the viability of MCF-7 and T47D cells at different glucose concentrations. J Exp Clin Med 2020; 37: 119–25. PMID: 33408552
Dubois V, Jardé T, Delort L, et al. Leptin induces a proliferative response in breast cancer cells but not in normal breast cells. Nutr Cancer 2014; 66: 645–55. doi:10.1080/01635581.2014.894104
Grossmann ME, Ray A, Dogan S, et al. Balance of adiponectin and leptin modulates breast cancer cell growth. Cell Res 2008; 18: 1154–6. doi:10.1038/cr.2008.293
Popko K, Gorska E, Stelmaszczyk-Emmel A, et al. Proinflammatory cytokines IL-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res 2010; 15: 120–2. doi:10.1186/2047-783X-15-S2-120/FIGURES/3
Cleary MP, Hu X, Grossmann ME, et al. Prevention of mammary tumorigenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response? Exp Biol Med 2007; 232: 70–80 doi:10.3181/00379727-207-2320070
Rogozina OP, Bonorden MJL, Seppanen CN, et al. Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis. Cancer Prev Res 2011; 4: 568–81. doi:10.1158/1940-6207.CAPR-10-0140
Dogan S, Cicekdal MB, Ozorhan U, et al. Roles of adiponectin and leptin signaling-related microRNAs in the preventive effects of calorie restriction in mammary tumor development. Appl Physiol Nutr Metab 2021; 46: 866–76. doi:10.1139/APNM-2020-1000
Cicekdal MB, Kazan BT, Tuna BG, et al. Effects of two types of calorie restriction on methylation levels of Adiponectin Receptor 1 (AdipoR1) and Leptin receptor overlapping transcript (Leprot) in a MMTV-TGF-α breast cancer mouse model. Br J Nutr 2020; 123: 1079. doi:10.1017/S0007114520000471
Guvenc Tuna B, Cleary MP, Demirel PB, et al. Leptin signaling in liver tissue of a transgenic breast cancer mouse model. Cureus 2020; 12: e6737. doi:10.7759/cureus.6737
Hao JQ, Zhang QK, Zhou YX, et al. Association between circulating leptin concentration and G-2548A gene polymorphism in patients with breast cancer: A meta-analysis. Arch Med Sci 2019; 15: 275–83. doi:10.5114/aoms.2018.75638
Liang X, Wang S, Wang X, et al. Leptin promotes the growth of breast cancer by upregulating the wnt/β-catenin pathway. Exp Ther Med 2018; 16: 767–71. doi:10.3892/etm.2018.6212
Dogan S, Ray A, Cleary MP. The influence of different calorie restriction protocols on serum pro-inflammatory cytokines, adipokines and IGF-I levels in female C57BL6 mice: Short term and long term diet effects. Meta Gene 2017; 12: 22–32. doi:10.1016/J.MGENE.2016.12.013
Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006; 393: 7–20. doi:10.1042/BJ20051578
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
